BPMC insider transaction filings
Blueprint Medicines Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-07-21. Screen BPMC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-21 | 4 | Namouni Fouad — PRESIDENT, R & D | Grant/award (A): 39,456 · Disposition to issuer (D): 83,281 · Code (U): 31,956 · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 26,125 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +3 more | EDGAR |
| 2025-07-21 | 4 | Landsittel Michael — Chief Financial Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 51,102 · Code (U): 43,175 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 26,000 (derivative) · Disposition to issuer (D): 19,500 (derivative) · +6 more | EDGAR |
| 2025-07-21 | 4 | Dable Habib J — Director | Disposition to issuer (D): 3,902 · Code (U): 8,742 · Disposition to issuer (D): 7,950 (derivative) · Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 4,570 (derivative) | EDGAR |
| 2025-07-21 | 4 | Hurley Ariel — Principal Accounting Officer | Grant/award (A): 2,460 · Disposition to issuer (D): 16,146 · Code (U): 3,378 · Disposition to issuer (D): 2,250 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 11,399 (derivative) · +6 more | EDGAR |
| 2025-07-21 | 4 | Tsai John — Director | Disposition to issuer (D): 3,902 · Code (U): 8,742 · Disposition to issuer (D): 7,950 (derivative) · Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 4,570 (derivative) | EDGAR |
| 2025-07-21 | 4 | COATS LONNEL — Director | Disposition to issuer (D): 6,144 · Disposition to issuer (D): 11,818 (derivative) · Disposition to issuer (D): 10,909 (derivative) · Disposition to issuer (D): 10,909 (derivative) · Disposition to issuer (D): 4,875 (derivative) · Disposition to issuer (D): 3,188 (derivative) · +4 more | EDGAR |
| 2025-07-21 | 4 | Hewes L. Becker — Chief Medical Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 50,165 · Code (U): 1,607 · Disposition to issuer (D): 13,490 (derivative) · Disposition to issuer (D): 26,125 (derivative) · Disposition to issuer (D): 9,115 (derivative) · +3 more | EDGAR |
| 2025-07-21 | 4 | Carter Percy H. — Chief Scientific Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 56,614 · Code (U): 17,894 · Disposition to issuer (D): 39,200 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +2 more | EDGAR |
| 2025-07-21 | 4 | Rossi Christina — Chief Operating Officer | Grant/award (A): 39,456 · Disposition to issuer (D): 82,374 · Code (U): 20,628 · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 6,500 (derivative) · Disposition to issuer (D): 28,500 (derivative) · +5 more | EDGAR |
| 2025-07-21 | 4 | Haviland Kate — Chief Executive Officer, Director | Grant/award (A): 129,210 · Disposition to issuer (D): 224,410 · Code (U): 70,729 · Disposition to issuer (D): 2 (derivative) · Disposition to issuer (D): 591 (derivative) · Disposition to issuer (D): 39,000 (derivative) · +7 more | EDGAR |
| 2025-07-21 | 4 | McCain Tracey L — EVP & Chief Legal Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 51,103 · Code (U): 37,092 · Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 39,000 (derivative) · +7 more | EDGAR |
| 2025-07-21 | 4 | Durso-Bumpus Debra — Chief People Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 51,103 · Code (U): 19,856 · Disposition to issuer (D): 15,367 (derivative) · Disposition to issuer (D): 30,500 (derivative) · Disposition to issuer (D): 21,125 (derivative) · +5 more | EDGAR |
| 2025-07-21 | 4 | Lee Philina — Chief Commercial Officer | Grant/award (A): 21,353 · Disposition to issuer (D): 50,165 · Code (U): 13,184 · Disposition to issuer (D): 8,650 (derivative) · Disposition to issuer (D): 6,928 (derivative) · Disposition to issuer (D): 20,669 (derivative) · +2 more | EDGAR |
| 2025-07-21 | 4 | Albers Jeffrey W. — Director | Disposition to issuer (D): 5,777 · Code (U): 144,755 · Disposition to issuer (D): 92,500 (derivative) · Disposition to issuer (D): 170,000 (derivative) · Disposition to issuer (D): 110,500 (derivative) · Disposition to issuer (D): 90,000 (derivative) · +4 more | EDGAR |
| 2025-07-21 | 4 | Goldberg Mark Alan — Director | Disposition to issuer (D): 3,902 · Code (U): 18,254 · Disposition to issuer (D): 10,909 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,875 (derivative) · Disposition to issuer (D): 4,500 (derivative) · +4 more | EDGAR |
| 2025-07-21 | 4 | Beckman Daniella — Director | Disposition to issuer (D): 3,902 · Code (U): 10,842 · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 4,570 (derivative) | EDGAR |
| 2025-07-21 | 4 | Borisy Alexis — Director | Disposition to issuer (D): 3,902 · Code (U): 74,160 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,875 (derivative) · Disposition to issuer (D): 4,500 (derivative) · Disposition to issuer (D): 4,500 (derivative) · +3 more | EDGAR |
| 2025-07-21 | 4 | Seely Lynn — Director | Disposition to issuer (D): 3,902 · Code (U): 13,254 · Disposition to issuer (D): 21,818 (derivative) · Disposition to issuer (D): 10,909 (derivative) · Disposition to issuer (D): 10,909 (derivative) · Disposition to issuer (D): 7,500 (derivative) · +6 more | EDGAR |
| 2025-07-08 | 4 | Rossi Christina — CHIEF OPERATING OFFICER | Sale (S): 1,172 @ $128.25 | EDGAR |
| 2025-07-08 | 4 | Carter Percy H. — CHIEF SCIENTIFIC OFFICER | Sale (S): 1,051 @ $128.25 | EDGAR |
| 2025-06-24 | 4 | Albers Jeffrey W. — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | Dable Habib J — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | COATS LONNEL — Director | Grant/award (A): 3,902 @ $12,812 | EDGAR |
| 2025-06-24 | 4 | Tsai John — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | Goldberg Mark Alan — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | Beckman Daniella — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | Seely Lynn — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-24 | 4 | Borisy Alexis — Director | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-05 | 4 | Carter Percy H. — CHIEF SCIENTIFIC OFFICER | Sale (S): 241 @ $127.88 · Sale (S): 2,418 @ $127.88 | EDGAR |
| 2025-05-29 | 4 | Albers Jeffrey W. — Director | Option exercise (M): 5,000 @ $36.05 · Sale (S): 4,350 @ $101.02 · Sale (S): 650 @ $101.93 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Rossi Christina — CHIEF OPERATING OFFICER | Sale (S): 804 @ $100.14 · Sale (S): 1,413 @ $100.67 · Sale (S): 57 @ $101.72 | EDGAR |
| 2025-05-07 | 4 | Rossi Christina — CHIEF OPERATING OFFICER | Sale (S): 607 @ $100.97 · Sale (S): 1,343 @ $101.77 · Sale (S): 180 @ $102.82 · Sale (S): 144 @ $103.56 | EDGAR |
| 2025-05-07 | 4 | Hurley Ariel — PRINCIPAL ACCOUNTING OFFICER | Option exercise (M): 2,752 @ $54.13 · Sale (S): 1,252 @ $102.51 · Sale (S): 1,400 @ $103.57 · Sale (S): 100 @ $104.78 · Option exercise (M): 2,752 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Haviland Kate — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 600 @ $85.47 · Sale (S): 598 @ $86.14 · Sale (S): 1,200 @ $87.34 · Sale (S): 100 @ $88.59 | EDGAR |
| 2025-03-26 | 4 | Rossi Christina — CHIEF OPERATING OFFICER | Sale (S): 2,274 @ $95.02 | EDGAR |
| 2025-03-17 | 4 | Albers Jeffrey W. — Director | Sale (S): 5,766 @ $88.80 | EDGAR |
| 2025-03-14 | 4 | Albers Jeffrey W. — Director | Option exercise (M): 7,500 @ $36.05 · Sale (S): 5,700 @ $87.62 · Sale (S): 1,800 @ $88.37 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Hewes L. Becker — CHIEF MEDICAL OFFICER | Sale (S): 4,863 @ $88.80 · Sale (S): 2,691 @ $87.42 · Sale (S): 2,541 @ $87.98 | EDGAR |
| 2025-03-07 | 4 | Rossi Christina — CHIEF OPERATING OFFICER | Sale (S): 6,495 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Namouni Fouad — PRESIDENT, R & D | Sale (S): 6,489 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | McCain Tracey L — EVP AND CHIEF LEGAL OFFICER | Sale (S): 5,262 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Lee Philina — CHIEF COMMERCIAL OFFICER | Sale (S): 3,733 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Landsittel Michael — CHIEF FINANCIAL OFFICER | Sale (S): 5,284 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Hurley Ariel — PRINCIPAL ACCOUNTING OFFICER | Sale (S): 1,326 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Haviland Kate — CHIEF EXECUTIVE OFFICER | Sale (S): 16,151 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Durso-Bumpus Debra — CHIEF PEOPLE OFFICER | Sale (S): 5,157 @ $88.80 | EDGAR |
| 2025-03-07 | 4 | Carter Percy H. — CHIEF SCIENTIFIC OFFICER | Sale (S): 3,530 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Hewes L. Becker — CHIEF MEDICAL OFFICER | Grant/award (A): 11,000 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Lee Philina — CHIEF COMMERCIAL OFFICER | Grant/award (A): 11,000 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Hurley Ariel — PRINCIPAL ACCOUNTING OFFICER | Grant/award (A): 6,506 @ $0 · Sale (S): 775 @ $89.63 · Sale (S): 238 @ $90.92 · Sale (S): 631 @ $92 · Sale (S): 484 @ $93.42 · Sale (S): 1,075 @ $95.16 · +1 more | EDGAR |
Recent 8-K events — Blueprint Medicines Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-07-18 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-06-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BPMC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →